Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C23H29NO3.ClH |
| Molecular Weight | 403.942 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCOC(=O)C1(CCN(CCC(O)C2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=HGEAGOBQOIMDQV-UHFFFAOYSA-N
InChI=1S/C23H29NO3.ClH/c1-2-27-22(26)23(20-11-7-4-8-12-20)14-17-24(18-15-23)16-13-21(25)19-9-5-3-6-10-19;/h3-12,21,25H,2,13-18H2,1H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C23H29NO3 |
| Molecular Weight | 367.4813 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
PHENOPERIDINE is an opioid analgesic partly metabolized to meperidine in the liver. It is derived from pethidine by replacing the N methyl by a phenyl propanol chain. It is reputed to be a typical morphine-like analgesic characterized by its high potency, rapid onset of action, the intensity of its peak effect and the short duration of its pharmacological effects. It is used in general anesthesia.
Originator
Approval Year
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1330 ng × min/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4027103/ |
2 mg single, intravenous dose: 2 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
PHENOPERIDINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
193 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4027103/ |
2 mg single, intravenous dose: 2 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
PHENOPERIDINE plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
21.17% |
15 μg/kg bw single, intravenous dose: 15 μg/kg bw route of administration: Intravenous experiment type: SINGLE co-administered: |
PHENOPERIDINE plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. | 2009-04-29 |
|
| Contemporary strategies to preserve renal function during cardiac and vascular surgery. | 2003 |
|
| Motor neuropathy associated with cimetidine. | 1980-10-11 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:06 GMT 2025
by
admin
on
Mon Mar 31 17:45:06 GMT 2025
|
| Record UNII |
1D9C1OK7KZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
31984
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
100000085293
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
1D9C1OK7KZ
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
3627-49-4
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
SUB03758MIG
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
19260
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
106508
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | RxNorm | ||
|
222-846-1
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
DTXSID10957657
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | |||
|
m8632
Created by
admin on Mon Mar 31 17:45:06 GMT 2025 , Edited by admin on Mon Mar 31 17:45:06 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |